David Cho, PHARM D in Woodside, CA - Pharmacist

David Cho, PHARM D is a Pharmacist based in Woodside, California. David Cho is licensed to practice in California (license number 59606) and his current practice location is 850 Woodside Rd, Woodside, California. He can be reached at his office (for appointments etc.) via phone at (650) 365-3682.

NPI number for David Cho is 1841590213 and his current mailing address is 2715 Darlene Ct, Castro Valley, California. He does not participate in medicare program and thus does not accept medicare assignments. His NPI Number is 1841590213.

Contact Information

	David Cho, PHARM D
	850 Woodside Rd, Woodside, CA 94061-3746
	(650) 365-3682
	Not Available

Healthcare Provider's Profile

Full Name	David Cho
Gender	Male
Speciality	Pharmacist
Location	850 Woodside Rd, Woodside, California
Accepts Medicare Assignments	Does not participate in Medicare Program. He may not accept medicare assignment.

NPI Data:

NPI Number: 1841590213
Provider Enumeration Date: 11/01/2010
Last Update Date: 11/01/2010

Medical Identifiers

Medical identifiers for David Cho such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1841590213	NPI	-	NPPES

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
183500000X	Pharmacist	59606 (California)	Primary

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. David Cho is NOT enrolled with medicare and thus cannot prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
David Cho, PHARM D 2715 Darlene Ct, Castro Valley, CA 94546-2801 Ph: (510) 508-8594	David Cho, PHARM D 850 Woodside Rd, Woodside, CA 94061-3746 Ph: (650) 365-3682

News Archive

Arcadia Biosciences and Vilmorin collaborate to develop and market NUE wheat

Arcadia Biosciences, Inc., an agricultural technology company focused on developing technologies and products that benefit the environment and human health, and Vilmorin, the world's fourth-largest seed company and the global leader in wheat genetics and seed, today announced that they have reached an agreement for the development and commercialization of Nitrogen Use Efficient (NUE) wheat.

Adequate building ventilation can help tackle airborne transmission of Covid-19

Preventing airborne transmission of Covid-19 should be the next front of the battle against the virus, argue experts from the University of Surrey.

Study shows how deadly Candida albicans might be rendered harmless

Candida albicans is a double agent: In most of us, it lives peacefully, but for people whose immune systems are compromised by HIV or other severe illnesses, it is frequently deadly. Now a new study from Johns Hopkins and Harvard Medical School shows how targeting a specific fungal component might turn the fungus from a lion back into a kitten.

Rare ADCY9 mutations linked to non-syndromic oral clefts in Puerto Ricans

Today at the 45th Annual Meeting & Exhibition of the American Association for Dental Research, researcher Carmen Buxó-Martínez, University of Puerto Rico, San Juan, will present a study titled "Identification of Rare ADCY9 Mutations and Non-syndromic Oral Clefts in Puerto Ricans." The AADR Annual Meeting is being held in conjunction with the 40th Annual Meeting of the Canadian Association for Dental Research.

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.

David Cho, PHARM D - Pharmacist in Woodside, CA